These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3217275)

  • 41. Antitumoral effects of liarozole in androgen-dependent and independent R3327-Dunning prostate adenocarcinomas.
    Dijkman GA; Van Moorselaar RJ; Van Ginckel R; Van Stratum P; Wouters L; Debruyne FM; Schalken JA; de Coster R
    J Urol; 1994 Jan; 151(1):217-22. PubMed ID: 8254818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia.
    Peschke P; Hahn EW; Wenz F; Lohr F; Braunschweig F; Wolber G; Zuna I; Wannenmacher M
    Radiat Res; 1998 Oct; 150(4):423-30. PubMed ID: 9768856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A high-fat diet does not influence the growth of the Dunning R3327-H transplantable prostate adenocarcinoma.
    Schwab ED; Normolle D; Pacis RA; Cho SS; Pienta KJ
    Anticancer Res; 1998; 18(5A):3603-7. PubMed ID: 9858946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of vimentin in rat prostatic tumors.
    Bussemakers MJ; Verhaegh GW; van Bokhoven A; Debruyne FM; Schalken JA
    Biochem Biophys Res Commun; 1992 Feb; 182(3):1254-9. PubMed ID: 1540169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryosurgical ablation of the normal ventral prostate plus adjuvant does not protect Copenhagen rats from Dunning prostatic adenocarcinoma challenge.
    Friedman EJ; Orth CR; Brewton KA; Ponniah S; Alexander RB
    J Urol; 1997 Oct; 158(4):1585-8. PubMed ID: 9302178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth of Dunning transplantable prostate adenocarcinomas in rats fed diets with various fat contents.
    Clinton SK; Palmer SS; Spriggs CE; Visek WJ
    J Nutr; 1988 Jul; 118(7):908-14. PubMed ID: 3392600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential protooncogene expression during rat liver regeneration.
    Thompson NL; Mead JE; Braun L; Goyette M; Shank PR; Fausto N
    Cancer Res; 1986 Jun; 46(6):3111-7. PubMed ID: 3516391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-galactosidase as a marker of HSP70 promoter induction in Dunning R3327 prostate carcinoma cells.
    Roigas J; Wallen ES; Loening SA; Moseley PL
    Urol Res; 1997; 25(4):251-5. PubMed ID: 9286033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Point mutations in the Ki-ras2 gene of codon 12 in the Dunning R-3327 Prostatic Adenocarcinoma system.
    Blount LV; Cooke DB
    Prostate; 1996 Jan; 28(1):44-50. PubMed ID: 8545280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.
    Wake N; Isaacs J; Sandberg AA
    Cancer Res; 1982 Oct; 42(10):4131-42. PubMed ID: 7105009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer.
    Isaacs JT; Hukku B
    Prostate; 1988; 13(2):165-88. PubMed ID: 3174494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Murine monoclonal antibodies reactive with a variety of androgen independent Dunning rat prostate adenocarcinoma sublines also reactive with human prostate adenocarcinoma.
    Tjota A; Lee MT; Isaacs JT; Kadohama N; Lee CL
    J Urol; 1991 Jul; 146(1):205-12. PubMed ID: 2056591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic alterations in human prostate cancer: a review of current literature.
    Ozen M; Pathak S
    Anticancer Res; 2000; 20(3B):1905-12. PubMed ID: 10928125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GM-CSF restoration of a differentiated (growth factor-regulated) phenotype in an anaplastic tumor.
    Rubenstein M; Shaw M; Targonski P; McKiel CF; Dubin A; Guinan P
    Urol Res; 1991; 19(5):309-12. PubMed ID: 1949430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The radiation sensitivities of R3327-H and R3327-AT rat prostate adenocarcinomas.
    Thorndyke C; Meeker BE; Thomas G; Lakey WH; McPhee MS; Chapman JD
    J Urol; 1985 Jul; 134(1):191-8. PubMed ID: 4009821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dunning rat prostate tumors and cultured cell lines fail to express human prostate carcinoma-associated antigens.
    Newhall KR; Isaacs JT; Wright GL
    Prostate; 1990; 17(4):317-25. PubMed ID: 1701250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
    Oltean S; Febbo PG; Garcia-Blanco MA
    Clin Exp Metastasis; 2008; 25(6):611-9. PubMed ID: 18523850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.